You are here



The pharmaceutical company has acquired 100% of the shares in Geadic Biotech, where the two companies were working on a molecular test for the early detection of endometrial cancer

London Technology Week

The Catalan equity crowfunding platform specializing in health has chosen Cambridge to start operations in 2017


The '' website is an initiative of Biocat and Biotechgate, the leading European database in healthcare and the life sciences and a source of basic information for investors

Carlos Buesa, CEO Oryzon

The company has signed loan agreements with banking institutions on top of the €16.5-millions capital increase at the end of last year

Equip IDP Pharma

The company is working on new agents to treat leukemia, particularly multiple myeloma

Equip Ability Pharma

The Catalan firm has granted an exclusive license for its anticancer agent, potentially valued at more than €20 millions

laura soucek

The spin-off of the Vall d’Hebron Institute of Oncology (VHIO) and ICREA will put most of the funds towards preclinical validation of a treatment for multiform glioblastoma, one of the most aggressive brain tumors

Laboratori Biochemize

The biotechnology firm designs production processes for molecules with high value-added and conducts chemical and microbiological analyses for industrial companies

planta merck mollet

This investment comes on the heels of the €5 millions and €8.6 millions announced in 2015 and 2016 respectively and will go towards ongoing improvements to the plant

TEI Bio Barcelona

The organization aims to hold several events throughout the year in order to create an active community of scientists, entrepreneurs and business people in the biosciences sector